Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
BOSTON, April 20, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
BOSTON, April 20, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Fourth major clinical trial to select PharmAla Biotech as supplier in Australia VANCOUVER, British Columbia,…
Fourth major clinical trial to select PharmAla Biotech as supplier in Australia VANCOUVER, British Columbia,…
– Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid…
– Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid…
Preclinical data from LBIO-115 exon 51 program demonstrate superior levels of exon-skipping that result in…
Preclinical data from LBIO-115 exon 51 program demonstrate superior levels of exon-skipping that result in…
WARREN, N.J., April 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
WARREN, N.J., April 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
First Randomized, Placebo-Controlled Clinical Study to Report Successful E-Cigarette Cessation Benefit with Pharmacological Treatment Study…
First Randomized, Placebo-Controlled Clinical Study to Report Successful E-Cigarette Cessation Benefit with Pharmacological Treatment Study…
Further follow-up ILUVIEN® PALADIN data to be presented onsite at the annual Association for Research…
Further follow-up ILUVIEN® PALADIN data to be presented onsite at the annual Association for Research…
RESEARCH TRIANGLE PARK, N.C., April 20, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
RESEARCH TRIANGLE PARK, N.C., April 20, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) — Nusano, Inc., a company reshaping the production…
NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) — Nusano, Inc., a company reshaping the production…